8-K
false00018024500001802450mspr:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00001PerShareMember2022-11-082022-11-080001802450mspr:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf1150PerShareMember2022-11-082022-11-0800018024502022-11-082022-11-080001802450us-gaap:CommonClassAMember2022-11-082022-11-08

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 08, 2022

 

 

MSP Recovery, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39445

84-4117825

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2701 Le Jeune Road

Floor 10

 

Coral Gables, Florida

 

33134

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (305) 614-2222

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A common stock, par value $0.0001 per share

 

MSPR

 

The NASDAQ Global Market

Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share

 

MSPRW

 

The NASDAQ Global Market

Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $0.0001 per share

 

MSPRZ

 

The NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


 

 


Item 2.02 Results of Operations and Financial Condition.

 

On November 8, 2022, MSP Recovery, Inc. issued a press release announcing its results of operations for the third quarter ended September 30, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit is furnished as part of this Current Report on Form 8-K.

 

 

 

 

 

 

Exhibit No.

Description of Document

 

 

99.1

Press Release issued by MSP Recovery, Inc. on November 8, 2022.

104

Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

MSP Recovery, Inc.

 

 

 

 

Date:

November 8, 2022

By:

/s/ Calvin Hamstra

 

 

 

Calvin Hamstra, Chief Financial Officer

 


EX-99.1

 

https://cdn.kscope.io/6fdf23d04c53bdeec2d6d1308fc57728-img168358461_0.jpg 

 

For Investors:

ICR, Inc.

Marc Griffin

Marc.Griffin@icrinc.com

 

For Media:

ICR, Inc.

MSP@icrinc.com

 

 

MSP Recovery Announces Fiscal Third Quarter 2022 Financial Results
Recognized Gain on Debt Extinguishment of $63 million During the Quarter

Paid Value of Potentially Recoverable Claims Grew to $89.2 billion During Quarter

Increase in Total Claims Recovery Income and Service Income of $3.0 million over the Second Quarter

Purchased additional $48.2 million in CCRAs and signed a $7.5 million licensing deal for LifeWallet

 

Coral Gables, Florida, – November 8, 2022 – MSP Recovery, Inc. (NASDAQ: MSPR)("MSPR," "MSP Recovery," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced financial results for the third quarter ended September 30, 2022.

MSPR continued to successfully execute and advance its business strategy as the paid value of recoverable claims increased by about $870 million to $89.2 billion in the third quarter from the second quarter 2022, reflecting continued strong demand from health plans, providers, and self-insured entities for MSPR’s services, expertise, and portfolio of revenue streams. MSPR also acquired $48.2 million in recovery rights, whereby MSPR acquired 100% of the future recoveries associated with assigned claims.

The Company settled an accident-related case for $1.75 million, with the average recovery on claims settled exceeding 2x the Paid Value of Potentially Recoverable Claims ("PVPRC"). The Company also settled with a group health plan, recovering $1.15 million for an increase in Total Claims Recovery Income and Service Income of $3 million from the second quarter. Initial payments received through the third quarter on individual demand claims, averaged a recovery multiple of 2.1x the projected PVPRC.

Based on current cases pending in litigation, and the volume of claims being processed as it relates to individual demands, the Company believes it has a clear path towards monetizing assets. Additionally, since recovery rights are liquidated damages, the assets owned by MSPR increase in value to the extent that interest continues to accrue on liquidated damages claims.
 

The Company also reached a new warrant agreement with Brickell Key Investments, LP. (“Brickell Key”), that reduced debt by $63 million and resulted in a $40 million per year reduction in accrued interest. By exchanging part

1


 

of their debt into an equity position, Brickell Key demonstrates their continued confidence in the Company.
 

LifeWallet entered into a licensing agreement with a new client for a $7.5 million fee and expected prospective fees of $1 million per year for continued servicing. LifeWallet also launched the LifeWallet Legal Referral Service to enable LifeWallet to generate revenue from lawyers across the nation. The LifeChain blockchain technology is being implemented for several clients and MSPR expects to begin monetizing the technology during the fourth quarter. Last month, MSPR announced that it had expanded its partnership with Tokenology Labs to include the development of multiple blockchain initiatives.
 

“During the third quarter, we expanded our portfolio of recoverable claims and added to our potential revenue streams while significantly reducing our debt,” said MSP Recovery Founder and CEO, John H. Ruiz. “This is all further proof of the growing recognition in the healthcare, healthcare data and law community of MSPR’s unique value proposition.”

“Some of our most exciting new potential revenue opportunities come thanks to the astounding early success of LifeWallet, which we launched less than a year ago, said MSP Recovery Co-Founder and Chief Legal Officer, Frank C. Quesada.

“LifeWallet is a powerful and effective tool for both patients and healthcare providers alike. Thanks to our expanded partnership with Tokenology, LifeWallet’s LifeChain will connect providers and payers to tokenized medical claims, which is expected to transform standard medical claim forms into unique digital versions on blockchain (NFTs or non-fungible tokens).”

“We continue to build on what we believe is an insurmountable head start when it comes to creating and deploying advanced technology tools alongside industry-leading legal acumen to wring waste, inefficiency and fraud from the healthcare claim process,” added Mr. Ruiz. “We have seen a large number of healthcare solutions and are confident that our unique technology continues to disrupt the healthcare system as it relates to data ingestion as well as patient efficiencies and proper payments.”

 


 

 

Third Quarter 2022 Financial Highlights

Revenue: Total revenue for the third quarter of 2022 was $8.3 million, up 234% from the third quarter of 2021.
Operating loss: Operating loss for the third quarter of 2022 was $78.9 million, compared with $3.1 million for the third quarter of 2021. Adjusted operating loss for third quarter was $12.5 million excluding non-cash claims amortization expense of $66.3 million.1

2


 

Net loss: Net loss for the third quarter of 2022 was $26.1 million and $0.6 million to controlling members, or net loss per share of $0.01 per share, based on 69.6 million weighted average shares outstanding. Adjusted net loss for the third quarter was $12.8 million excluding the non-cash item noted above and $13.1 million of non-cash expenses related to paid in kind interest, partially offset by a $63.4 million gain on debt extinguishment and $2.7 million gain from the change in fair value of warrants and derivative liabilities.1
Liquidity: As of September 30, 2022, cash and cash equivalents were $14.3 million. In addition, we announced potential additional capital resources totaling $1.5 billion which includes $1 billion from the Company Common Stock Purchase Agreement, $200 million from the Investment Capacity Agreement, by and among MSP Recovery and Virage Capital Management, LP., based on anticipated initial closing under the Virage ICA, and up to an additional $250 million from the Prudent Sale.
Gain on debt extinguishment: During the third quarter, the Company reported a gain on debt extinguishment of $63.4 million after reducing its obligation with Brickell Key Investment, LP., from $143 million to $80 million.
(1)
Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.

 

Third Quarter 2022 Key Metrics

Since announcing the business combination with Lionheart Acquisition Corporation II, our portfolio has continued to grow. Below is detail on the increase in our portfolio since the announcement:

Select Portfolio Metrics

 

As of

September 30

 

 

December 31

 

 

March 31

 

 

June 30

 

 

September 30

 

(in millions)

2021

 

 

2021

 

 

2022

 

 

2022

 

 

2022

 

Total Paid Amount

$

67,162

 

 

$

364,438

 

 

$

366,879

 

 

$

370,154

 

 

$

373,294

 

Paid Value of Potentially Recoverable Claims (PVPRC)

 

15,248

 

 

 

86,629

 

 

 

87,284

 

 

 

88,305

 

 

 

89,176

 

Billed Value of Potentially Recoverable Claims (BVPRC)

 

55,366

 

 

 

363,231

 

 

 

367,836

 

 

 

371,321

 

 

 

376,125

 

As of September 30, 2022, MSPR had the following developments:

Total Paid Amount of owned claims has increased to $373.3 billion, as of September 30, 2022, up 2% from $364.4 billion as of December 31, 2021 and up 456% from $67.2 billion from September 30, 2021.
Paid Value of Potential Recoverable Claims grew to $89.2 billion, as of September 30, 2022, up 3% from $86.6 billion as of December 31, 2021 and up 485% from $15.2 billion from September 30, 2021.
Currently in data matching or settlement discussions with 27.9% of the Auto Insurance Market.
We have expanded our work with Tokenology on tokenized healthcare initiative on the Polygon network. This initiative, combined with LifeWallet’s biometric technology targets fraud and abuse in the U.S. healthcare system.

Portfolio Growth:

MSPR seeks assignment of recovery rights from secondary payers and providers by acquiring the recovery rights to claims from secondary payers via Claims Cost Recovery Agreements (“CCRA”). The Company utilizes its proprietary internal data analytics platform to review claims and identify which have probable recovery paths. MSPR’s assets are these irrevocable assignments of health claims recovery rights that are automatic, all-encompassing and superior to other interests supported by Federal and State laws and regulations. The table below outlines the

3


 

Company's growth in data received in the most recent periods. The amounts represent data received from current and new assignors:

 

MSP's Recovery Portfolio Claims Growth By Year

As of

 

Claims Count

 

 

PVPRC

 

 

BVPRC

 

 

 

 

 

(thousands)

 

 

(millions)

 

 

(millions)

 

 

December 31, 2021

 

 

632,919

 

 

$

86,630

 

 

$

363,231

 

 

March 31, 2022

 

 

6,689

 

 

 

655

 

 

 

4,605

 

 

June 30, 2022

 

 

7,348

 

 

 

1,020

 

 

 

3,484

 

 

September 30, 2022

 

 

7,452

 

 

 

871

 

 

 

4,804

 

 

Total

 

 

654,408

 

 

$

89,176

 

 

$

376,125

 

 

 

Demand Letters:

MSPR recently announced a strategy whereby the Company is sending out individual demand letters on identified recoverable claims to responsible payers for prompt payment. We expect this strategy to result in more predictable and visible revenues. The table below outlines specific dollar amounts identified by the Company, broken down by litigation and demand letter type, that it plans to pursue against different responsible parties:

 

Recoveries Being Sought by Category

 

($'s in millions)

Identified Incidents

 

 

Total Claims

 

 

Paid Amounts

 

 

Billed Amounts Sought

 

Accident Related:

 

 

 

 

 

 

 

 

 

 

 

Data Matching (1)

 

341,622

 

 

 

61,944,178

 

 

$

4,964.4

 

 

$

18,906.5

 

Demand Letters (2):

 

 

 

 

 

 

 

 

 

 

 

1st Party Demands

 

11,790

 

 

 

1,327,547

 

 

$

117.6

 

 

$

818.1

 

3rd Party Demands

 

16,202

 

 

 

2,433,171

 

 

 

227.4

 

 

 

1,631.2

 

Case and Lien Recoveries

 

1,809

 

 

 

212,087

 

 

 

18.5

 

 

 

77.1

 

Fraud & Misconduct Cases:

 

 

 

 

 

 

 

 

 

 

 

Private Lien Resolution Programs (3)

84

 

 

 

19,484

 

 

 

2.8

 

 

 

14.1

 

Big Pharma/Product Liability (2)

 

1,683,811

 

 

 

56,635,380

 

 

 

5,274.7

 

 

 

17,032.1

 

Group Health Plan Recovery

 

1,073

 

 

 

13,311

 

 

 

2.1

 

 

 

10.9

 

(1)
Data Matching represents potential recovery opportunities the Company has identified via court orders or agreements with primary payers. These represent potential recoveries that MSP could receive from a portion of our settlement discussions with 27.9% of Auto Insurance industry or via demand letters.
(2)
As previously announced June 13th and 27th 2022, MSP initiated billing amounts to primary payers (i.e., property and casualty insurers) and big pharma, giving these parties the opportunity to pay without the need for litigation or extended litigation.
(3)
PLRPs are established to resolve health care liens asserted by private health insurance providers in mass tort settlements. MSPR is actively working with various lien resolution administrators to recover on those owned claims for which manufacturers have already settled other lawsuits and established PLRPs.



 

Financial Outlook

MSP Recovery is providing guidance for its full year 2022 as follows:

Portfolio 2022 Guidance: Exceeded target for 2022 for growth in PVPRC by 3.5 times.

4


 

2022 Recoveries Guidance: We previously provided guidance with respect to Total Gross Recoveries, which we expected to be approximately $992 million during 2022.(1),. While we still anticipate that the amount of those Total Gross Recoveries will be achieved, due to various factors, including, but not limited to litigation delays, we now believe that we will achieve a substantial portion of these Total Gross Recoveries during 2023. The guidance provided was and is an estimate based on management’s current knowledge and various assumptions. The nature of the Company’s business, and the timing and amount of Total Gross Recoveries that will be achieved, are inherently unpredictable, and the Company cannot provide assurances regarding the timing or amount of Total Gross Recoveries that will ultimately be achieved.
 

Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.

(1)
Total Gross Recoveries is the cash received or to be received by MSPR for recoveries that may be through consolidated or non-consolidated entities.

Quarterly Conference Call

MSP Recovery will host a conference call and live webcast to review the Company’s third quarter results for investors and analysts at 8:00 a.m. Eastern Time on Wednesday, November 9, 2022. To access this call, we encourage you to pre-register using this link: MSP Recovery Q3 2022 Earnings Pre Registration. A replay of the webcast will be archived and accessible at https://investors.msprecovery.com/.

 

About MSP Recovery

Founded in 2014, MSP Recovery has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions, while innovating technologies to help save lives. For more information, visit: www.msprecovery.com.

Forward Looking Statements
 

5


 

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, including for example guidance for 2022 portfolio recovery and total gross recoverables. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance or results and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by MSP Recovery herein speaks only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for MSPR to predict or identify all such events or how they may affect it. MSPR has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, MSPR’s ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; litigation results; the validity of the assignments of claims to MSPR; the ability to successfully expand the scope of MSPR’s claims or obtain new data and claims from MSPR’s existing assignor base or otherwise; MSPR’s ability to innovate and develop new solutions, and whether those solutions will be adopted by MSPR’s existing and potential assignors; negative publicity concerning healthcare data analytics and payment accuracy; and those other factors included in MSPR’s S-1 Registration Statement dated July 7, 2022, Quarterly Reports on Form 10-Q and other reports filed by it with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

6


 

MSP RECOVERY, INC. and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

September 30,

 

 

December 31,

 

(In thousands except per share amounts)

 

2022

 

 

2021

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

14,268

 

 

$

1,664

 

Restricted cash

 

 

11,420

 

 

 

-

 

Accounts receivable

 

 

7,525

 

 

 

-

 

Affiliate receivable

 

 

1,774

 

 

 

4,070

 

Indemnification asset

 

 

752,510

 

 

 

-

 

Prepaid expenses and other current assets

 

 

32,660

 

 

 

13,304

 

Total current assets

 

 

820,157

 

 

 

19,038

 

Property, plant and equipment, net

 

 

2,480

 

 

 

750

 

Deferred tax asset

 

 

857

 

 

 

-

 

Intangible assets, net

 

 

2,077,571

 

 

 

84,218

 

Investment in rights to claim recovery cash flows

 

 

3,673,610

 

 

 

-

 

Total assets

 

$

6,574,675

 

 

$

104,006

 

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

32,468

 

 

$

4,609

 

Affiliate payable

 

 

19,822

 

 

 

45,252

 

Commission payable

 

 

540

 

 

 

465

 

Deferred service fee income

 

 

249

 

 

 

249

 

Derivative Liability

 

 

10,065

 

 

 

-

 

Warrant Liability

 

 

4,700

 

 

 

-

 

Guaranty obligation

 

 

752,510

 

 

 

-

 

Other current liabilities

 

 

62,638

 

 

 

3,489

 

Total current liabilities

 

 

882,992

 

 

 

54,064

 

Claims financing obligation and notes payable

 

 

170,844

 

 

 

106,805

 

Loan from related parties

 

 

125,759

 

 

 

-

 

Interest payable

 

 

1,471

 

 

 

94,545

 

Total liabilities

 

$

1,181,066

 

 

$

255,414

 

 

 

 

 

 

 

 

Class A common stock subject to possible redemption, 1,129,589 shares at redemption value as of September 30, 2022.

 

 

1,356

 

 

 

-

 

 

 

 

 

 

 

 

Stockholders' Equity (Deficit):

 

 

 

 

 

 

Class A common stock, $0.0001 par value; 5,500,000,000 shares authorized; 72,909,609 issued and outstanding as of September 30, 2022

 

$

7

 

 

$

-

 

Class V common stock, $0.0001 par value; 3,250,000,000 shares authorized; 3,148,720,212 issued and outstanding as of September 30, 2022

 

 

315

 

 

 

-

 

Additional paid-in capital

 

 

201,656

 

 

 

-

 

Members' equity

 

 

-

 

 

 

(155,756

)

Accumulated deficit

 

 

(23,537

)

 

 

-

 

Total Stockholders' Equity (Deficit)

 

$

178,441

 

 

$

(155,756

)

Non-controlling interest

 

 

5,213,812

 

 

 

4,348

 

Total equity

 

$

5,392,253

 

 

$

(151,408

)

Total liabilities and equity

 

$

6,574,675

 

 

$

104,006

 

 

7


 

MSP RECOVERY, INC. and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

 

 

 

For the three months ended September 30,

 

 

For the nine months ended September 30

 

(In thousands except per share amounts)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Claims recovery income

 

$

2,571

 

 

$

48

 

 

$

3,999

 

 

$

63

 

Claims recovery service income

 

 

5,748

 

 

 

2,439

 

 

 

17,795

 

 

 

9,213

 

Total Claims Recovery

 

$

8,319

 

 

$

2,487

 

 

$

21,794

 

 

$

9,276

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Cost of claim recoveries

 

 

1,160

 

 

 

15

 

 

 

1,861

 

 

 

23

 

Claims amortization expense

 

 

66,331

 

 

 

47

 

 

 

92,866

 

 

 

114

 

General and administrative

 

 

6,621

 

 

 

2,871

 

 

 

17,049

 

 

 

8,207

 

Professional fees

 

 

5,875

 

 

 

2,539

 

 

 

10,931

 

 

 

5,606

 

Professional fees - legal

 

 

8,014

 

 

 

26

 

 

 

34,251

 

 

 

56

 

Depreciation and amortization

 

 

103

 

 

 

89

 

 

 

254

 

 

 

256

 

Total operating expenses

 

 

88,104

 

 

 

5,587

 

 

 

157,212

 

 

 

14,262

 

Operating Loss

 

$

(79,785

)

 

$

(3,100

)

 

$

(135,418

)

 

$

(4,986

)

Interest expense

 

 

(13,083

)

 

 

(6,990

)

 

 

(34,475

)

 

 

(19,579

)

Other (expense) income, net

 

 

63,138

 

 

 

(169

)

 

 

63,175

 

 

 

1,154

 

Change in fair value of warrant and derivative liabilities

 

 

2,670

 

 

 

-

 

 

 

(11,683

)

 

 

-

 

Net loss before provision for income taxes

 

$

(27,060

)

 

$

(10,259

)

 

$

(118,401

)

 

$

(23,411

)

Provision for income tax benefit

 

 

-

 

 

 

-

 

 

 

326

 

 

 

-

 

Net loss

 

$

(27,060

)

 

$

(10,259

)

 

$

(118,075

)

 

$

(23,411

)

Less: Net (income) loss attributable to non-controlling members

 

 

26,597

 

 

 

(16

)

 

 

116,324

 

 

 

(16

)

Net loss attributable to controlling members

 

$

(463

)

 

$

(10,275

)

 

$

(1,751

)

 

$

(23,427

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted weighted average shares outstanding, Class A Common Stock

 

 

69,036,899

 

 

N/A

 

 

 

53,138,474

 

 

N/A

 

Basic and diluted net income per share, Class A Common Stock

 

$

(0.01

)

 

N/A

 

 

$

(0.03

)

 

N/A

 

 

8


 

Non-GAAP Financial Measures

MSP RECOVERY, INC. and Subsidiaries

Non-GAAP Reconciliation

(Unaudited)

 

 

Three months ended

 

Nine months ended

 

(In thousands)

September 30, 2022

 

September 30, 2022

 

GAAP Operating Loss

$

(79,785

)

 

(135,418

)

Share based compensation

 

 

 

20,055

 

Claims amortization expense

 

66,331

 

 

92,866

 

Adjusted operating loss

$

(13,454

)

 

(22,497

)

 

 

 

 

 

GAAP Net Loss

$

(27,060

)

 

(118,075

)

Share based compensation

 

 

 

20,055

 

Claims amortization expense

 

66,331

 

 

92,866

 

Gain on debt extinguishment

 

(63,367

)

 

(63,367

)

Paid-in-kind Interest

 

13,083

 

 

34,475

 

Change in fair value of warrant and derivative liabilities

 

(2,670

)

 

11,683

 

Adjusted net loss

$

(13,683

)

 

(22,363

)

 

In addition to the financial measures prepared in accordance with GAAP, this press release also contains Non-GAAP financial measures. We consider "Net loss excluding non-cash and one-time expenses" and "Operating loss excluding non-cash or one-time items" as non-GAAP financial measures and important indicators of performance and useful metrics for management and investors to evaluate our business's ongoing operating performance on a consistent basis across reporting periods. Net loss excluding non-cash and one-time expenses represents Net loss adjusted for certain non-cash and non-recurring expenses, and Operating loss excluding non-cash or one-time items represents Operating loss adjusted for certain non-cash and non-recurring expenses. These measures provide useful information to investors, and a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these Non-GAAP measures will be included in Management's Discussion and Analysis in the Form 10-Q.

9